Theophylline concentrations in the emergency treatment of acute bronchial asthma
Affiliations
- Division of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Affiliations
- Division of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Correspondence
- Address reprint requests to Richard Nowak, MD, Division of Emergency Medicine, Henry Ford Hospital, W. Grand Boulevard, Detroit, MI 48202, USA

Affiliations
- Division of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Correspondence
- Address reprint requests to Richard Nowak, MD, Division of Emergency Medicine, Henry Ford Hospital, W. Grand Boulevard, Detroit, MI 48202, USA
Affiliations
- Division of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Affiliations
- the Division of Allergy and Immunology, Henry Ford Hospital, Detroit, Michigan, USA.
Affiliations
- Division of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Affiliations
- the Division of Allergy and Immunology, Henry Ford Hospital, Detroit, Michigan, USA.
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.
Abstract
Ninety-three patients presenting with acute asthma to the emergency department were studied to determine theophylline levels and their relationship to airway obstruction, history of prior medication use, and side effects of treatment. The mean pretreatment theophylline level was 6.4 μg/ml. Patients on long-acting preparations had significantly higher levels than those on short-acting medications (p < 0.05). The mean post-treatment theophylline level was 16.7 μg/ml. Twenty-three patients had toxic levels post-treatment but none of these had a major adverse reaction. Twenty of these patients had been taking long-acting preparations. Fifty percent of the patients with symptoms of gastrointestinal toxicity had theophylline levels below 15 μg/ml. There was no correlation between the theophylline level or change in level and the degree of airway obstruction as measured by pulmonary function testing. Clinical findings are not reliable predictors of theophylline levels. Patients taking long-acting theophylline products should receive a lowered loading dose.
To access this article, please choose from the options below
Purchase access to this article
Claim Access
If you are a current subscriber with Society Membership or an Account Number, claim your access now.
Subscribe to this title
Purchase a subscription to gain access to this and all other articles in this journal.
Institutional Access
Visit ScienceDirect to see if you have access via your institution.
Article Tools
Related Articles
Searching for related articles..
